Bio Plus Co., Ltd (KOSDAQ:099430)

Market Cap	371.70B -12.1%
Revenue (ttm)	90.90B +36.9%
Net Income	15.00B +6.0%
EPS	149.00 -39.7%
Shares Out	61.54M
PE Ratio	40.54
Forward PE	n/a
Dividend	70.00 (1.21%)
Ex-Dividend Date	Dec 29, 2025

Volume	483,145
Average Volume	338,593
Open	6,040.00
Previous Close	6,040.00
Day's Range	5,760.00 - 6,080.00
52-Week Range	4,510.00 - 8,420.00
Beta	0.47
RSI	57.53
Earnings Date	Apr 3, 2026

About Bio Plus

Bio Plus Co., Ltd engages in the research and development, production, and sale of bio products in South Korea. It offers dermal fillers under the SkinPlus – Hyal, Bio+ Dew, HyalDew, DeneB Classic, Stilea, and 3-Senses brand names. The company also provides medical products, including InterBlock, an absorbable anti-adhesion barrier; Synofil, a synovial fluid replacement; and Blad-Care, a solution to temporarily improve cystitis symptoms. In addition, it offers mesotherapy products, such as skin rejuvenation products under the Kiara Reju name; S...

• Industry: Medical - Specialties
• Sector: Healthcare
• Founded: 2003
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 099430

Financial Performance

In 2025, Bio Plus's revenue was 90.90 billion, an increase of 36.87% compared to the previous year's 66.41 billion. Earnings were 15.00 billion, an increase of 6.01%.